-->

Joel Shacker - Core One CEO Director

CLABF Stock  USD 0.02  0.04  63.00%   

Insider

Joel Shacker is CEO Director of Core One Labs
Age 33
Phone888-452-6731
Webhttps://core1labs.com

Core One Management Efficiency

The company has return on total asset (ROA) of (0.5279) % which means that it has lost $0.5279 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.9978) %, meaning that it generated substantial loss on money invested by shareholders. Core One's management efficiency ratios could be used to measure how well Core One manages its routine affairs as well as how well it operates its assets and liabilities.
Core One Labs has accumulated 380 K in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Core One Labs has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Core One until it has trouble settling it off, either with new capital or with free cash flow. So, Core One's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core One Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core to invest in growth at high rates of return. When we think about Core One's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

INSIDER Age

Tommy DiraimondoJanux Therapeutics
39
CFA CPAJanux Therapeutics
45
Byron JDJanux Therapeutics
60
Charles WinterJanux Therapeutics
55
Wayne MDJanux Therapeutics
63
Andy MeyerJanux Therapeutics
41
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada. Core One operates under Biotechnology classification in the United States and is traded on OTC Exchange. Core One Labs [CLABF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Core One Labs Leadership Team

Elected by the shareholders, the Core One's board of directors comprises two types of representatives: Core One inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core. The board's role is to monitor Core One's management team and ensure that shareholders' interests are well served. Core One's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core One's outside directors are responsible for providing unbiased perspectives on the board's policies.
Brad Eckenweiler, Founder Advisor
Elizabeth Matthews, Head Affairs
Santiago Ferro, Chief Officer
Jan Burian, Chief Officer
Geoffrey Balderson, S CFO
Joel Shacker, CEO Director
FRSC OC, Ex Chairman

Core Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Core One a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Core Pink Sheet

Core One financial ratios help investors to determine whether Core Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Core with respect to the benefits of owning Core One security.